Biopharmaceuticals Engineering
Home » Initiatives »
About Biopharmaceuticals Engineering at UD
Biopharmaceuticals—medicines produced from living cells—have the potential to revolutionize the treatment of cancers, Alzheimer’s Disease, and inflammatory disorders such as rheumatoid arthritis.
The University of Delaware is home to the National Institute for Innovation in Biopharmaceuticals, a national partnership of 120 universities, community colleges, corporations, government agencies and nonprofit organizations aimed at advancing biopharmaceutical manufacturing innovation and workforce development. The institute director is Kelvin Lee, Gore Professor of Chemical & Biomolecular Engineering at the University of Delaware. NIIMBL is one of 14 Manufacturing USA institutes focused on fundamentally advancing U.S. competitiveness in key industries.
Many researchers across the University of Delaware, including faculty members and students in the College of Engineering, are working on key questions around biopharmaceutical innovation, such as how to extend the shelf life of these medicines and much more.
226,636 sq ft
The Ammon-Pinizzotto Biopharmaceutical Innovation Center now under construction on UD’s STAR Campus will house NIIMBL, the Delaware Biotechnology Institute, and UD’s biomedical engineering program, as well as research laboratories in pharmaceutical discovery and molecular and medical sciences.
Recent News
Prof. Kunjapur wins 2024 BioInnovation Institute & Science Prize for Innovation
This award recognizes researchers who have made significant advances using protected or licensed materials, such as proprietary drugs, diagnostics, or other healthcare-related technologies.
Fresh Hope for Chronic Wounds
FDA-approved wound management products include UD-developed biomaterials.
Mastering molecule mechanics
UD researchers shed light on formulation, manufacturing challenges in diabetes, obesity medications.
High-throughput innovation
Researchers in the lab of April Kloxin are using an advanced ‘bioprinter’ to help them study and test new therapeutics.
New building blocks
UD engineers create bacteria that can synthesize an unnatural amino acid
Delaware First: Engineering the Future
Transformational gift from David and Connie Helwig will establish UD’s new Institute for Engineering Driven Health.